12. Niidome T, Huang L (2002) Gene therapy progress and prospects: nonviral vectors. Gene Ther 9: 1647–1652. 13. Papapetrou EP, Zoumbos NC, Athanassiadou A (2005) Genetic modification of hematopoietic stem cells with nonviral systems: past progress and future prospects. Gene Ther 12 Suppl 1: S118–130. 14. Izsva´k Z, Hackett PB, Cooper LJN, Ivics Z (2010) Translating Sleeping Beauty transposition into cellular therapies: Victories and challenges. BioEssays 32: 756–767. 15. Jackson DA, Juranek S, Lipps HJ (2006) Designing nonviral vectors for efficient gene transfer and long-term gene expression. Mol Ther 14: 613–626. 16. Geurts AM, Yang Y, Clark KJ, Liu G, Cui Z, et al. (2003) Gene transfer into genomes of human cells by the Sleeping Beauty transposon system. Mol Ther 8: 108–117. 17. Hackett PB, Largaespada DA, Cooper LJ (2010) A transposon and transposase system for human application. Mol Ther 18: 674–683. 18. Ivics Z, Hackett PB, Plasterk RH, Izsva´k Z (1997) Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 91: 501–510. 19. Izsva´k Z, Ivics Z, Plasterk RH (2000) Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates. J Mol Biol 302: 93–102. 20. Collier LS, Largaespada DA (2007) Transposons for cancer gene discovery: Sleeping Beauty and beyond. Genome Biol 8(Suppl 1): S15. 21. Dalsgaard T, Moldt B, Sharma N, Wolf G, Schmitz A, et al. (2009) Shielding of Sleeping Beauty DNA transposon-delivered transgene cassettes by heterologous insulators in early embryonal cells. Mol Ther 17: 121–130. 22. Ma´te´s L, Chuah MK, Belay E, Jerchow B, Manoj N, et al. (2009) Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates. Nat Genet 41: 753–761. 23. Xue X, Huang X, Nodland SE, Mates L, Ma L, et al. (2009) Stable gene transfer and expression in cord blood-derived CD34+ hematopoietic stem and progenitor cells by a hyperactive Sleeping Beauty transposon system. Blood 114: 1319–1330. 24. Giebel B, Punzel M (2008) Lineage development of hematopoietic stem and progenitor cells. Biol Chem 389: 813–824. 25. Arumugam P, Malik P (2010) Genetic therapy for b-thalassemia: from the bench to the bedside. Hematology Am Soc Hematol Educ Program 2010: 445–450. 26. Zhu JH, Kren BT, Park CW, Bilgim R, Wong PYP, et al. (2007) Erythroid- specific expression of b-globin by the Sleeping Beauty transposon for sickle cell disease. Biochemistry 46: 6844–6858. 27. Moreau-Gaudry F, Xia P, Jiang G, Perelman NP, Bauer G, et al. (2001) High- level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors. Blood 98: 2664–2672. 28. Zhu JH, Park CW, Sjeklocha L, Kren BT, Steer CJ (2010) High-Level genomic integration, epigenetic changes, and expression of Sleeping Beauty transgene. Biochemistry 49: 1507–1521. 29. Park CW, Park J, Kren BT, Steer CJ (2006) Sleeping Beauty transposition in the mouse genome is associated with changes in DNA methylation at the site of insertion. Genomics 88: 204–213. 30. Garrison BS, Yant SR, Mikkelsen JG, Kay MA (2007) Postintegrative gene silencing within the Sleeping Beauty transposition system. Mol Cell Biol 27: 8824–8833. 31. Chung JH, Whiteley M, Felsenfeld G (1993) A 59 element of the chicken b- globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila. Cell 74: 505–514. Erythroid-Specific Expression from Sleeping Beauty 32. Bell AC, West AG, Felsenfeld G (1999) The protein CTCF is required for the enhancer blocking activity of vertebrate insulators. Cell 98: 387–396. 33. Pikaart MJ, Recillas-Targa F, Felsenfeld G (1998) Loss of transcriptional activity of a transgene is accompanied by DNA methylation and histone deacetylation and is prevented by insulators. Genes Dev 12: 2852–2862. 34. Li CL, Emery DW (2008) The cHS4 chromatin insulator reduces gammare- troviral vector silencing by epigenetic modifications of integrated provirus. Gene Ther 15: 49–53. 35. Walisko O, Schorn A, Rolfs F, Devaraj A, Miskey C, et al. (2008) Transcriptional activities of the Sleeping Beauty transposon and shielding its genetic cargo with insulators. Mol Ther 16: 359–369. 36. Johnson SE, Shah N, Panoskaltsis-Mortari A, LeBien TW (2005) Murine and human IL-7 activate STAT5 and induce proliferation of normal human pro-B cells. J Immunol 175: 7325–7331. 37. Addya S, Keller MA, Delgrosso K, Ponte CM, Vadigepalli R, et al. (2004) Erythroid-induced commitment of K562 cells results in clusters of differentially expressed genes enriched for specific transcription regulatory elements. Physiol Genomics 19: 117–130. 38. Huang X, Haley K, Wong M, Guo H, Lu C, et al. (2010) Unexpectedly high copy number of random integration but low frequency of persistent expression of the Sleeping Beauty transposase following trans delivery in primary human T cells. Hum Gene Ther 21: 1577–1590. 39. Mates L, Chuah MK, Belay E, Jerchow B, Manoj N, et al. (2009) Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates. Nat Genet 41: 753–761. 40. Cherry SR, Biniszkiewicz D, van Parijs L, Baltimore D, Jaenisch R (2000) Retroviral expression in embryonic stem cells and hematopoietic stem cells. Mol Cell Biol 20: 7419–7426. 41. Park CW, Kren BT, Largaespada DA, Steer CJ (2005) DNA methylation of Sleeping Beauty with transposition into the mouse genome. Genes Cells 10: 763–776. 42. Aker M, Tubb J, Groth AC, Bukovsky AA, Bell AC, et al. (2007) Extended core sequences from the cHS4 insulator are necessary for protecting retroviral vectors from silencing position effects. Hum Gene Ther 18: 333–343. 43. Niwa H, Yamamura K, Miyazaki J (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108: 193–199. 44. Suzuki Y, Takeda Y, Ikuta T (2008) Immunoblotting conditions for human hemoglobin chains. Anal Biochem 378: 218–220. 45. Gassmann M, Grenacher B, Rohde B, Vogel J (2009) Quantifying Western blots: pitfalls of densitometry. Electrophoresis 30: 1845–1855. 46. Douay L, Giarratana MC (2009) Ex vivo generation of human red blood cells: a new advance in stem cell engineering. Meth Mol Biol 482: 127–140. 47. Giarratana MC, Kobari L, Lapillonne H, Chalmers D, Kiger L, et al. (2005) Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotech 23: 69–74. 48. La Motte-Mohs RN, Herer E, Zu´ n˜iga-Pflu¨cker JC (2005) Induction of T-cell development from human cord blood hematopoietic stem cells by Delta-like 1 in vitro. Blood 105: 1431–1439. 49. Gaines P, Berliner N (2005) Differentiation and characterization of myeloid cells. Curr Protoc Immunol Chapter 22: Unit 22F 25. 50. Shelton JB, Shelton JR, Schroeder WA (1984) High-Performance liquid- chromatographic separation of globin chains on a large-pore C-4 column. J Liq Chrom 7: 1969–1977. PLoS ONE | www.plosone.org 10 December 2011 | Volume 6 | Issue 12 | e29110